Chromosomal instability induced in cancer can enhance macrophage-initiated immune responses that include anti-tumor IgG
Open Access
- 28 May 2024
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Abstract
Solid tumors generally exhibit chromosome copy number variation, which is typically caused by chromosomal instability (CIN) in mitosis. The resulting aneuploidy can drive evolution and associates with poor prognosis in various cancer types as well as poor response to T-cell checkpoint blockade in melanoma. Macrophages and the SIRPα-CD47 checkpoint are understudied in such contexts. Here, CIN is induced in poorly immunogenic B16F10 mouse melanoma cells using spindle assembly checkpoint MPS1 inhibitors that generate persistent micronuclei and diverse aneuploidy while skewing macrophages toward a tumoricidal ‘M1-like’ phenotype based on markers and short-term anti-tumor studies. Mice bearing CIN-afflicted tumors with wild-type CD47 levels succumb similar to controls, but long-term survival is maximized by SIRPα blockade on adoptively transferred myeloid cells plus anti-tumor monoclonal IgG. Such cells are the initiating effector cells, and survivors make de novo anti-cancer IgG that not only promote phagocytosis of CD47-null cells but also suppress tumor growth. CIN does not affect the IgG response, but pairing CIN with maximal macrophage anti-cancer activity increases durable cures that possess a vaccination-like response against recurrence.Keywords
All Related Versions
Funding Information
- National Institutes of Health (U01 CA254886)
- National Institutes of Health (P01 CA265794)
- National Science Foundation (GRFP DGE-1845298)
- National Institutes of Health (F32 CA228285)
This publication has 50 references indexed in Scilit:
- Cells in the polyaneuploid cancer cell (PACC) state have increased metastatic potentialClinical & Experimental Metastasis, 2023
- MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerCancer Cell, 2022
- Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylationCell Reports, 2021
- Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune MicroenvironmentCell, 2019
- LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune ToleranceCell, 2018
- Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying CellsCancer Cell, 2018
- Genomic and Functional Approaches to Understanding Cancer AneuploidyCancer Cell, 2018
- SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid TumorsCurrent Biology, 2017
- Chromosome Mis-segregation Generates Cell-Cycle-Arrested Cells with Complex Karyotypes that Are Eliminated by the Immune SystemDevelopmental Cell, 2017
- Single-chromosome Gains Commonly Function as Tumor SuppressorsCancer Cell, 2017